Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Ann Thorac Surg. 2021 Oct;112(4):1095-1100. doi: 10.1016/j.athoracsur.2020.10.032. Epub 2020 Nov 27.
We explored the feasibility and safety of modified subxiphoid thoracoscopic thymectomy for patients with locally invasive thymomas.
Subxiphoid thoracoscopic thymectomy was performed on select patients with locally invasive thymomas (Masaoka stage III) using an auxiliary sternal retractor to create a larger operative field.
From June 2015 to March 2019, we performed modified subxiphoid thoracoscopic thymectomy on 48 patients with locally invasive thymomas: 39 patients had pericardium or lung infiltration and received a combination of a partial pericardium or lung wedge resection, and 9 patients had left innominate vein infiltration and underwent combined resection of the left innominate vein. Thoracoscopic thymectomy was performed from the subxiphoid pathway with an auxiliary sternal retractor in all 48 patients, and there were no conversions to median sternotomy. The median tumor size was 5 cm, and the maximal tumor size was 12 cm. The median blood loss was 50 mL. The median duration of chest tube placement was 3 days, and the median hospital stay was 4.5 days after surgery. All patients achieved a good recovery after surgery, and none had serious complications during the perioperative period. All patients underwent postoperative adjuvant radiotherapy and presented no local recurrence or distant metastasis until now.
Modified subxiphoid thoracoscopic thymectomy with an auxiliary sternal retractor makes minimally invasive thymectomy easier and safer to perform and is an alternative approach for some patients with locally invasive thymomas.
我们探索了改良剑突下入路胸腔镜胸腺切除术治疗局部侵袭性胸腺瘤患者的可行性和安全性。
对选择的局部侵袭性胸腺瘤(Masaoka 分期 III 期)患者采用辅助胸骨牵开器进行改良剑突下入路胸腔镜胸腺切除术,以创建更大的手术视野。
自 2015 年 6 月至 2019 年 3 月,我们对 48 例局部侵袭性胸腺瘤患者实施了改良剑突下入路胸腔镜胸腺切除术:39 例患者有心包或肺浸润,行部分心包或肺楔形切除术联合治疗;9 例患者有左无名静脉浸润,行左无名静脉联合切除术。48 例患者均经剑突下入路联合辅助胸骨牵开器行胸腔镜胸腺切除术,无中转正中开胸。肿瘤最大径 5cm,中位数 5cm;术中出血量中位数 50ml;胸腔引流管留置中位数 3 天;术后中位住院时间 4.5 天。所有患者术后均恢复良好,围手术期无严重并发症发生。所有患者术后均接受辅助放疗,随访至今未见局部复发或远处转移。
改良剑突下入路胸腔镜胸腺切除术联合辅助胸骨牵开器的应用使微创胸腺切除术更容易且更安全,对于部分局部侵袭性胸腺瘤患者是一种可行的选择。